跳至主要内容
临床试验/DRKS00024662
DRKS00024662招募中不适用

Pilot-study: serum neurofilament light chains as a marker for neurological manifestation in fabry disease

Medizinische Universität Wien0 个研究点目标入组 90 人开始时间: 2021年2月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Inclusion criteria - FD patients with neurological manifestations:
  • - Confirmed diagnosis of Fabry disease (presence of a disease-relevant GLA variant).
  • - Neurological manifestations (ascertained in clinical neurological status examinations, MRI examinations or patient history) at at least one examination time point.
  • - Age 18-80 years, ability to give informed consent.
  • Inclusion criteria - FD patients without neurological manifestations:
  • - Confirmed diagnosis of Fabry disease (presence of a disease-relevant GLA variant).
  • - No neurological manifestations (raised in clinical neurological status examinations, MRI examinations or patient history) at both examination time points.
  • - Age 18-80 years, ability to give informed consent.
  • Inclusion criteria - healthy subjects:
  • - No present neurological complaints or neurological diseases, especially no diseases already associated with elevated sNfL concentrations.

排除标准

  • Missing or doubtful ability to give informed consent.

研究者

相似试验